149 related articles for article (PubMed ID: 36754622)
1. Public information on shortages in the EU/EEA: improvements made between 2018 and 2020.
Abed I; Garcia Burgos J; Knudsen Y
Eur J Hosp Pharm; 2024 Jun; 31(4):344-347. PubMed ID: 36754622
[TBL] [Abstract][Full Text] [Related]
2. New regulatory strategies to manage medicines shortages in Europe.
Musazzi UM; Di Giorgio D; Minghetti P
Int J Pharm; 2020 Apr; 579():119171. PubMed ID: 32092455
[TBL] [Abstract][Full Text] [Related]
3. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
4. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
Tomić S; Sucić AF; Martinac AI
Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
[TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
6. Vaccination policies of immigrants in the EU/EEA Member States-the measles immunization example.
Bica MA; Clemens R
Eur J Public Health; 2018 Jun; 28(3):439-444. PubMed ID: 29136141
[TBL] [Abstract][Full Text] [Related]
7. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
Pashkov V; Soloviov A; Olefir A
Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
[TBL] [Abstract][Full Text] [Related]
8. Oral healthcare systems in the extended European union.
Widström E; Eaton KA
Oral Health Prev Dent; 2004; 2(3):155-94. PubMed ID: 15641621
[TBL] [Abstract][Full Text] [Related]
9. Current practices for respiratory syncytial virus surveillance across the EU/EEA Member States, 2017.
Mollers M; Barnadas C; Broberg EK; Penttinen P; ; Teirlinck AC; Fischer TK;
Euro Surveill; 2019 Oct; 24(40):. PubMed ID: 31595876
[TBL] [Abstract][Full Text] [Related]
10. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.
Qu L; Zou W; Wang Y; Wang M
Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689
[TBL] [Abstract][Full Text] [Related]
11. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
[TBL] [Abstract][Full Text] [Related]
12. Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparison.
Zeitoun JD; Lefèvre JH; Downing N; Bergeron H; Ross JS
PLoS One; 2014; 9(10):e109100. PubMed ID: 25333986
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Capture in Pharmaceutical Policy Making: The Case of National Medicine Agencies Related to the EU Falsified Medicines Directive.
Borup R; Traulsen JM; Kaae S
Pharmaceut Med; 2019 Jun; 33(3):199-207. PubMed ID: 31933284
[TBL] [Abstract][Full Text] [Related]
14. Fifty years of the European medicines regulatory network: reflections for strengthening intra-regional cooperation in the Region of the Americas.
Allchurch MH; Barbano DB; Pinheiro MH; Lazdin-Helds J
Rev Panam Salud Publica; 2016 May; 39(5):288-293. PubMed ID: 27706411
[TBL] [Abstract][Full Text] [Related]
15. Critical review on the Environmental Risk Assessment of medicinal products for human use in the centralised procedure.
Caneva L; Bonelli M; Papaluca-Amati M; Vidal JM
Regul Toxicol Pharmacol; 2014 Apr; 68(3):312-6. PubMed ID: 24447908
[TBL] [Abstract][Full Text] [Related]
16. When innovation outpaces regulations: The legal challenges for direct-to-patient supply of investigational medicinal products.
Malone M; Ferguson P; Rogers A; Mackenzie IS; Rorie DA; MacDonald TM
Br J Clin Pharmacol; 2022 Mar; 88(3):1115-1142. PubMed ID: 34390022
[TBL] [Abstract][Full Text] [Related]
17. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
Beattie S;
Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
[TBL] [Abstract][Full Text] [Related]
18. How to address medicines shortages: Findings from a cross-sectional study of 24 countries.
Vogler S; Fischer S
Health Policy; 2020 Dec; 124(12):1287-1296. PubMed ID: 33032846
[TBL] [Abstract][Full Text] [Related]
19. Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Filia A; Rota MC; Grossi A; Martinelli D; Prato R; Rezza G
Vaccine; 2022 Mar; 40(13):1987-1995. PubMed ID: 35190211
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
